Structural Characterization and Optimization of a Miconazole Oral Gel

The development of semisolid formulations, gels in particular, has raised the attention of scientists more and more over the last decades. Because of their biocompatibility, hydrophilic nature, and capacity of absorbing large quantities of water, hydrogels are still one of the most promising pharmaceutical formulations in the pharmaceutical industry. The purpose of this study is to develop an optimal formulation capable of incorporating a water-poorly soluble active ingredient such as miconazole used in the treatment of fungal infections with Candida albicans and Candida parapsilosis. A D-optimal design was applied to study the relationship between the formulation parameter and the gel characteristics. The independent parameters used in this study were the Carbopol 940 concentration (the polymer used to obtain the gel matrix), the sodium hydroxide amount, and the presence/absence of miconazole. Ten different dependent parameters (Y1–Y10) were evaluated (penetrometry, spreadability, viscosity, and tangential tension at 1 and 11 levels of speed whilst destructuring and during the reorganization of the gel matrix). The consistency of the gels ranged from 23.2 mm (GO2) to 29.6 mm (GM5). The least spreadable gel was GO7 (1384 mm2), whilst the gel that presented the best spreadability was GO1 (3525 mm2). The viscosity and the tangential stress at the selected levels (1 and 11) varied due to the different compositions of the proposed gels. The gels were also tested for drug content and antifungal activity. All determinations had satisfying results; the drug content was within limits accepted by Ph. Eur. 10 and all formulations containing miconazole exhibited antifungal activity. An optimal formulation with miconazole was attained, consisting of 0.84% Carbopol 940 and 0.32% sodium hydroxide.

[1]  L. Farczádi,et al.  Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design , 2022, Pharmaceutics.

[2]  D. V. Gowda,et al.  Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 32 Factorial Design , 2022, Polymers.

[3]  Mallesh Kurakula,et al.  Design and Development of Neomycin Sulfate Gel Loaded with Solid Lipid Nanoparticles for Buccal Mucosal Wound Healing , 2022, Gels.

[4]  G. Perlovich,et al.  Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation , 2022, Pharmaceutics.

[5]  R. Zaki,et al.  Formulation and Evaluation of Transdermal Gel Containing Tacrolimus-Loaded Spanlastics: In Vitro, Ex Vivo and In Vivo Studies , 2022, Polymers.

[6]  Z. Rahman,et al.  Versatility of Hydrogels: From Synthetic Strategies, Classification, and Properties to Biomedical Applications , 2022, Gels.

[7]  Mallesh Kurakula,et al.  QbD Supported Optimization of the Alginate-Chitosan Nanoparticles of Simvastatin in Enhancing the Anti-Proliferative Activity against Tongue Carcinoma , 2022, Gels.

[8]  P. Sampaio,et al.  Fungal infections diagnosis – Past, present and future , 2021, Research in Microbiology.

[9]  E. Bucio,et al.  Hydrogels Classification According to the Physical or Chemical Interactions and as Stimuli-Sensitive Materials , 2021, Gels.

[10]  M. Kwon,et al.  Recent advances in transdermal drug delivery systems: a review , 2021, Biomaterials Research.

[11]  Wafaa E. Soliman,et al.  Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery , 2021, Molecules.

[12]  G. Lollo,et al.  Nanocomposite systems for precise oral delivery of drugs and biologics , 2021, Drug Delivery and Translational Research.

[13]  Dina Febrina,et al.  Overview: Application of Carbopol 940 in Gel , 2021, Proceedings of the International Conference on Health and Medical Sciences (AHMS 2020).

[14]  C. Dehelean,et al.  Proniosomal Gel for Topical Delivery of Rutin: Preparation, Physicochemical Characterization and In Vitro Toxicological Profile Using 3D Reconstructed Human Epidermis Tissue and 2D Cells , 2021, Antioxidants.

[15]  Miguel O. Jara,et al.  Drug-Loaded Lipid-Core Micelles in Mucoadhesive Films as a Novel Dosage Form for Buccal Administration of Poorly Water-Soluble and Biological Drugs , 2020, Pharmaceutics.

[16]  M. Del Poeta,et al.  The Future of Antifungal Drug Therapy: Novel Compounds and Targets , 2020, Antimicrobial Agents and Chemotherapy.

[17]  M. Hasanpour,et al.  Evolution of morphology and morphology stability in PP/PA6/EPDM-g-MA reactive ternary blends using viscoelastic measurements , 2020, Rheologica Acta.

[18]  T. Emanuelli,et al.  Oleic acid-containing semisolid dosage forms exhibit in vivo anti-inflammatory effect via glucocorticoid receptor in a UVB radiation-induced skin inflammation model , 2019, Inflammopharmacology.

[19]  T. Emanuelli,et al.  Oleic acid-containing semisolid dosage forms exhibit in vivo anti-inflammatory effect via glucocorticoid receptor in a UVB radiation-induced skin inflammation model , 2019, Inflammopharmacology.

[20]  G. Jemec,et al.  Cutaneous candidiasis – an evidence‐based review of topical and systemic treatments to inform clinical practice , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  J. Meyle,et al.  Oral Mucosal Epithelial Cells , 2019, Front. Immunol..

[22]  Z. Yousaf,et al.  Synthesis of hydrogels and their emerging role in pharmaceutics , 2019, Biomedical Applications of Nanoparticles.

[23]  D. Lupuleasa,et al.  Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review , 2018, Marine drugs.

[24]  Ana Simões,et al.  A Tutorial for Developing a Topical Cream Formulation Based on the Quality by Design Approach. , 2018, Journal of pharmaceutical sciences.

[25]  R. Chandra,et al.  Oral controlled and sustained drug delivery systems , 2018 .

[26]  Dabao Zhang,et al.  A Coefficient of Determination for Generalized Linear Models , 2017 .

[27]  P. Destruel,et al.  In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond. , 2017, Drug discovery today.

[28]  Lan Zhang,et al.  Application of quality by design in the current drug development , 2016, Asian journal of pharmaceutical sciences.

[29]  Wan-ying Wu,et al.  Development and evaluation of miconazole mucoadhesive tablets for oropharyngeal candidiasis , 2017 .

[30]  Arijit Gandhi,et al.  Quality by Design (QbD) in Pharmaceutical Industry: Tools, Perspectives and Challenges , 2016 .

[31]  Muhammad Sohail Zafar,et al.  Role of antifungal medicaments added to tissue conditioners: A systematic review. , 2016, Journal of prosthodontic research.

[32]  D. Lupuleasa,et al.  Flow and Thixotropic Parameters for Rheological Characterization of Hydrogels , 2016, Molecules.

[33]  H. Hua,et al.  Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. , 2016, Oral diseases.

[34]  V. Shah,et al.  A science based approach to topical drug classification system (TCS). , 2015, International journal of pharmaceutics.

[35]  R. Shamsudin,et al.  The Use of D-Optimal Mixture Design in Optimizing Development of Okara Tablet Formulation as a Dietary Supplement , 2015, TheScientificWorldJournal.

[36]  G. K. Raju,et al.  Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.

[37]  V. K. Rai,et al.  Development of cellulosic polymer based gel of novel ternary mixture of miconazole nitrate for buccal delivery. , 2014, Carbohydrate polymers.

[38]  R. Charyulu,et al.  Formulation and Evaluation of Mucoadhesive Oral Gel Containing Miconazole Nitrate for Oral Candidiasis , 2013 .

[39]  A. C. Silva,et al.  Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. , 2013, Colloids and surfaces. B, Biointerfaces.

[40]  A. Kabra,et al.  Formulation and Evaluation of Gel Containing Miconazole Nitrate an Antifungal Agent , 2013 .

[41]  P. Delvenne,et al.  Miconazole, a pharmacological barrier to skin fungal infections , 2012, Expert opinion on pharmacotherapy.

[42]  D. Stevens Miconazole in the Treatment of Coccidioidomycosis , 1983, Drugs.

[43]  Sangeetha,et al.  FORMULATION AND EVALUATION OF BIOADHESIVE MICONAZOL E NITRATE GEL FOR VAGINAL CANDIDIASIS , 2012 .

[44]  R. N. Brogden,et al.  Miconazole: A Preliminary Review of its Therapeutic Efficacy in Systemic Fungal Infections , 2012, Drugs.

[45]  P. Wright,et al.  Effect of antifungal gels incorporated into a tissue conditioning material on the growth of Candida albicans. , 2010, Gerodontology.

[46]  P. Puranik,et al.  Carbopol Polymers: A Versatile Polymer for Pharmaceutical Applications , 2010 .

[47]  A. Ramadan Formulation and Evaluation of Bioadhesive Gels Containing Miconazole Nitrate , 2008 .

[48]  Seung Hun Lee,et al.  An Update of the Defensive Barrier Function of Skin , 2006, Yonsei medical journal.

[49]  G. E. El Maghraby,et al.  Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. , 2004, International journal of pharmaceutics.

[50]  Y. Capan,et al.  Physico-chemical and bioadhesive properties of polyacrylic acid polymers. , 1993, Die Pharmazie.

[51]  J Hadgraft,et al.  Transdermal drug delivery and cutaneous metabolism. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[52]  J. Cope Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release. , 1980, Journal of general microbiology.

[53]  G. R. Rao,et al.  Studies on the Mechanism of Action of Miconazole: Effect of Miconazole on Respiration and Cell Permeability of Candida albicans , 1974, Antimicrobial Agents and Chemotherapy.